Binding of dimeric aminoglycosides to the HIV-1 rev responsive element (RRE) RNA construct

Bioorg Med Chem Lett. 2001 May 7;11(9):1127-31. doi: 10.1016/s0960-894x(01)00149-4.

Abstract

Through a series of elegant fluorescence measurements, particularly through stopped-flow kinetic measurements, it was recently demonstrated that aminoglycoside antibiotics are able to bind to the HIV-1 Rev responsive element (RRE) RNA construct in more than a 1:1 stoichiometry (Lacourciere, K. A.; Stivers, J. T.; Marino, J. P. Biocheminstry 2000, 39, 5630). Here, we present the binding study results of dimeric neomycin ligands through fluorescence anisotropy studies, to the HIV-1 RRE RNA construct. The dimeric neomycin molecules are observed to be able to bind the HIV-1 RRE RNA construct approximately 17-fold higher when compared to the monomeric neomycin, lending evidence that there are indeed two or more neomycin binding sites within the HIV-1 RRE construct.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / chemical synthesis
  • Anti-Bacterial Agents / pharmacology*
  • Binding Sites / drug effects
  • Carbohydrate Sequence
  • HIV-1 / drug effects*
  • HIV-1 / genetics
  • Models, Molecular
  • Molecular Sequence Data
  • Neomycin / analogs & derivatives
  • Neomycin / metabolism
  • RNA, Viral / biosynthesis*
  • RNA, Viral / drug effects
  • RNA, Viral / genetics
  • Response Elements / drug effects*
  • Response Elements / genetics*
  • Spectrometry, Fluorescence

Substances

  • Anti-Bacterial Agents
  • RNA, Viral
  • Neomycin